antitrypsin deficiency known significant genetic risk factor copd carriers phenotype pimz phenotypes pizz pisz genetic epidemiological studies antitrypsin deficiency conducted copd patients concurrent controls used estimate risk factors phenotypic classes normal phenotype pimm NUMBER deficiency allele phenotypes pims pimz piss pisz pizz studies antitrypsin deficiency white caucasian copd populations NUMBER countries combined obtain estimates prevalence pis piz deficiency alleles combined copd cohorts odds ratios phenotypic classes antitrypsin deficiency calculated hypothetical population NUMBER million white copd patients united states america approach demonstrated NUMBER antitrypsin deficiency patients detected testing NUMBER million white copd patients NUMBER white concurrent controls odds ratios phenotypic classes white copd patients demonstrate highly significant decreases normal phenotype pimm significant change pims piss deficiency phenotypes highly significant increases prevalences pimz pisz pizz deficiency phenotypes result present study supports concept targeted screening antitrypsin deficiency countries large populations white caucasian copd patients alpha NUMBER alpha NUMBER non copd alpha NUMBER non copd non copd alpha NUMBER alpha NUMBER non copd alpha NUMBER